Cardiovascular Risk and Menopausal Symptoms Associated With Oral SERDs
Drs Vidula and Lu review the potential impact of cardiovascular health associated with oral selective estrogen receptor degraders (SERDs) and discuss how the risk of menopausal symptoms differ between oral SERDs and other endocrine therapies.
Neelima Vidula Janice Lu Ryan Haumschild Estrogen Receptors Degraders Er Her2 Metastatic Breast Cancer Bone Health
Source: ajmc.com